Cosmos Health Inc. (NASDAQ:COSM) CEO Buys $149,253.72 in Stock

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) CEO Grigorios Siokas acquired 257,334 shares of the stock in a transaction that occurred on Friday, December 20th. The stock was acquired at an average cost of $0.58 per share, for a total transaction of $149,253.72. Following the completion of the purchase, the chief executive officer now owns 3,774,314 shares in the company, valued at $2,189,102.12. The trade was a 7.32 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Cosmos Health Trading Down 4.5 %

Shares of NASDAQ:COSM traded down $0.03 during midday trading on Thursday, reaching $0.63. The company’s stock had a trading volume of 189,919 shares, compared to its average volume of 778,762. The business has a 50 day moving average price of $0.73 and a 200 day moving average price of $0.91. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. Cosmos Health Inc. has a 1 year low of $0.47 and a 1 year high of $1.65. The firm has a market cap of $14.65 million, a price-to-earnings ratio of -0.26 and a beta of 5.57.

About Cosmos Health

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.

Featured Stories

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.